Tissue inhibitor of matrix metalloproteinase (TIMP)-1 is upregulated by inflammatory factors, such as interleukin [10], and AF progression is associated with a gradual increase in matrix metallopeptidase 9 (MMP-9)/TIMP-1 [11]. Here, MMP9 is linked to atrial fibrillation.